최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.31 no.3, 2021년, pp.198 - 204
김종윤 (동덕여자대학교 약학대학) , 유기연 (동덕여자대학교 약학대학)
Background: Cardiovascular (CV) disease is known as one of the major causes of death from disease worldwide. Statin therapy plays a pivotal role in atherosclerotic cardiovascular disease (ASCVD) lowering the LDL-cholesterol level effectively. The purpose of this study was to evaluate the association...
Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015;132(17):1667-78.
de Fatima Marinho de Souza M, Gawryszewski VP, Ordunez P, Sanhueza A, Espinal MA. Cardiovascular disease mortality in the americas: Current trends and disparities. Heart 2012;98(16):1207-12.
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation 2019;139(10):e56-e528.
Jee SH, Jang Y, Oh DJ, et al. A coronary heart disease prediction model: the Korean Heart Study. BMJ open 2014;4(5):e005025.
Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: A systematic review. JAMA 2005;294(17):2203-9.
Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US preventive services task force. JAMA 2016;316(19):2008-2024.
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333(20):1301-1307.
Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001;292(5519):1160-4.
Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60.
Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 1998;81(5):582-7.
Rhee E, Kim HC, Kim JH, et al. 2018 guidelines for the management of dyslipidemia in Korea. Journal of Lipid and Atherosclerosis. 2019;8(2):78-131.
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm-2018 executive summary. Endocr Pract 2018;24(1):91-120.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-88.
Son KB, Bae S. Patterns of statin utilisation for new users and market dynamics in South Korea: A 13-year retrospective cohort study. BMJ open 2019;9(3):e026603.
Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016;37(39):2999-3058.
Kim S, Han S, Rane PP, Qian Y, Zhao Z, Suh HS. Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea. PLoS One 2020;15(1):e0228472.
Kwon JE, Kim Y, Hyun S, et al. Cholesterol lowering effects of low-dose statins in Korean patients. J lipid Atheroscler 2014;3(1):21-28.
Naito R, Miyauchi K, Daida H. Racial differences in the cholesterollowering effect of statin. J Atheroscler Thromb 2017;24(1):19-25.
Korea Centers for Disease Control & Prevention. Chronic disease status and issues 2019. Available from:http://nih.go.kr/gallery.es?mida20503020000&bid0003&b_list9&actview&list_no144581&nPage1&vlist_no_npage2&keyField&keyWord&orderby. Accessed May 01, 2021.
Kim HJ, Kim Y, Cho Y, Jun B, Oh KW. Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: Results from the Korea National Health and Nutrition Examination Survey, 1998-2012. Int J Cardiol 2014;174(1):64-72.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.